Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Not applicableUnknownNCT04780529
What this trial is testing

CART Therapy in Digestive System Tumors

Who this might be right for
Malignant Neoplasms of Digestive Organs
Innovative Cellular Therapeutics Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07333430
What this trial is testing

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization 60
Not applicableStudy completedNCT05433987
What this trial is testing

Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

Who this might be right for
HIV-1-infection
Centre Hospitalier de Cannes Simone Veil 20
Early research (Phase 1)Looking for participantsNCT06201416
What this trial is testing

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc. 48
Early research (Phase 1)Study completedNCT04768608
What this trial is testing

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Who this might be right for
Castrate-Resistant Prostate Cancer
Zhejiang University 3
Early research (Phase 1)Active Not RecruitingNCT05646082
What this trial is testing

Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma

Who this might be right for
Refractory HIV Associated Kaposi Sarcoma
Imperial College London 15
Early research (Phase 1)UnknownNCT02799680
What this trial is testing

Allogeneic CART-33 for Relapsed/Refractory CD33+ AML

Who this might be right for
Relapsed and/or Refractory CD33+ AML
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 12
Early research (Phase 1)Active Not RecruitingNCT03549442
What this trial is testing

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Testing effectiveness (Phase 2)UnknownNCT03614858
What this trial is testing

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Who this might be right for
Leukemia, B-cell
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 20
Testing effectiveness (Phase 2)Looking for participantsNCT06695013
What this trial is testing

Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL

Who this might be right for
B-NHLCART Therapy
Ruijin Hospital 144
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Very early researchUnknownNCT03814447
What this trial is testing

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shanghai 6th People's Hospital 10
Not applicableLooking for participantsNCT07234110
What this trial is testing

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Who this might be right for
Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableLooking for participantsNCT07143617
What this trial is testing

Exploratory Clinical Study on the Safety of STR-P004

Who this might be right for
Autoimmune Diseases
Beijing GoBroad Hospital 39
Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Very early researchNot Yet RecruitingNCT07458659
What this trial is testing

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Chulalongkorn University 3
Testing effectiveness (Phase 2)Study completedNCT02092116
What this trial is testing

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir

Who this might be right for
HIV I Infection
Bionor Immuno AS 26
Not applicableLooking for participantsNCT07051525
What this trial is testing

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Who this might be right for
LeukemiaCART TherapyTransplantation, Stem Cell+1 more
Peter MacCallum Cancer Centre, Australia 214
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Next Page